全文获取类型
收费全文 | 3235篇 |
免费 | 224篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 84篇 |
妇产科学 | 89篇 |
基础医学 | 456篇 |
口腔科学 | 72篇 |
临床医学 | 346篇 |
内科学 | 703篇 |
皮肤病学 | 64篇 |
神经病学 | 306篇 |
特种医学 | 78篇 |
外科学 | 372篇 |
综合类 | 37篇 |
预防医学 | 182篇 |
眼科学 | 55篇 |
药学 | 274篇 |
中国医学 | 23篇 |
肿瘤学 | 311篇 |
出版年
2023年 | 28篇 |
2022年 | 52篇 |
2021年 | 85篇 |
2020年 | 55篇 |
2019年 | 61篇 |
2018年 | 95篇 |
2017年 | 66篇 |
2016年 | 83篇 |
2015年 | 76篇 |
2014年 | 116篇 |
2013年 | 145篇 |
2012年 | 204篇 |
2011年 | 268篇 |
2010年 | 134篇 |
2009年 | 124篇 |
2008年 | 199篇 |
2007年 | 232篇 |
2006年 | 181篇 |
2005年 | 202篇 |
2004年 | 182篇 |
2003年 | 184篇 |
2002年 | 174篇 |
2001年 | 43篇 |
2000年 | 36篇 |
1999年 | 48篇 |
1998年 | 44篇 |
1997年 | 25篇 |
1996年 | 16篇 |
1995年 | 25篇 |
1994年 | 18篇 |
1993年 | 16篇 |
1992年 | 24篇 |
1991年 | 21篇 |
1990年 | 15篇 |
1989年 | 19篇 |
1988年 | 29篇 |
1987年 | 17篇 |
1986年 | 10篇 |
1985年 | 14篇 |
1984年 | 8篇 |
1983年 | 11篇 |
1982年 | 10篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1972年 | 5篇 |
1971年 | 5篇 |
1970年 | 4篇 |
排序方式: 共有3471条查询结果,搜索用时 15 毫秒
1.
Antony E. Shrimpton Robert L. Schelper Reinhold P. Linke John Hardy Richard Crook Dennis W. Dickson Takashi Ishizawa Richard L. Davis 《Neuropathology》2007,27(3):228-232
Over 100 mutations in the presenilin‐1 gene (PSEN1) have been shown to result in familial early onset Alzheimer disease (EOAD), but only a relatively few give rise to plaques with an appearance like cotton wool (CWP) and/or spastic paraparesis (SP). A family with EOAD, seizures and CWP was investigated by neuropathological study and DNA sequencing of the PSEN1 gene. Aβ was identified in leptomeningeal vessels and in cerebral plaques. A single point mutation, p.L420R (g.1508T > G) that gives rise to a missense mutation in the eighth transmembrane (TM8) domain of PS1 was identified in two affected members of the family. p.L420R (g.1508T > G) is the mutation responsible for EOAD, seizures and CWP without SP in this family. 相似文献
2.
Antony J. Stockwell 《Community dentistry and oral epidemiology》1987,15(5):273-276
An epidemiological survey of the oral health needs of 1144 elderly patients was conducted in hospitals and nursing homes in Western Australia. Patients were categorised as being either totally dependent (requiring intensive nursing care) or partially dependent (requiring nursing supervision). Of all patients the mean age was 80.2 yr, 70% were women, 74% were edentulous, and 70% needed some form of prosthetic care. Of all dentate patients 56% needed dental scaling (and 17% needed complex periodontal treatment), 47% needed some restorative treatment (with a mean need per patient of 1.1 coronal restorations and 0.4 radicular restoration), and 29% needed one or more dental extractions (with a mean need of 1.4 extractions per patient). Partially dependent patients had statistically significant higher needs for prosthetic work than did totally dependent patients, while the converse applied to extraction needs, but in all other aspects the needs of the two categories of patient did not differ significantly. 相似文献
3.
H W Snyder J H Bertram D H Henry D D Kiprov W B Benny A Mittelman G L Messerschmidt S K Cochran W Perkins J P Balint 《AIDS (London, England)》1991,5(10):1257-1260
Thirty-seven HIV-infected homosexual men with thrombocytopenia (less than 100 x 10(9)/l) received protein A immunoadsorption treatments to remove platelet-sensitizing immunoglobulin (Ig) G and circulating immune complexes (CIC) from plasma. Patients received an average of six treatments each, consisting of 250 ml plasma over a 3-week period. Clinical improvement in hemorrhagic symptoms associated with substantial increase in platelet counts was achieved in 18 patients. These responses were maintained over a median follow-up period of more than 7 months in 14 evaluable patients who were not lost to follow-up (three patients relapsed in 2 weeks and one received another therapy). Generally, moderate transient treatment-related side-effects included fever, musculoskeletal pain, chills and nausea. A transient serum sickness-like reaction was observed in seven patients, leading to termination of treatment in two. Clinical responses were associated with significant decreases in levels of platelet-sensitizing Ig, including CIC. Stimulation of broadly cross-reactive anti-antigen-binding fragment [F(ab)2], antibodies contributed to these responses. Protein A immunoadsorption is an effective alternative treatment for HIV-associated thrombocytopenia. 相似文献
4.
5.
D. Osoba Benny Zee David Warr Jean Latreille Leonard Kaizer Joseph Pater 《Supportive care in cancer》1997,5(4):307-313
The purpose was to measure the effects of postchemotherapy nausea and vomiting (PCNV) on health-related quality of life (HQL) in patients receiving either moderately or highly emetogenic chemotherapy. The study sample consisted of 832 chemotherapy-naive patients with cancer who received either moderately or highly emetogenic chemotherapy as part of multicenter trials of new antiemetics. The patients completed the self-report European Organization for Research and Cancer (EORTC) core Quality of Life Questionnaire (QLQ-C30) before chemotherapy (baseline) and 1 week (day 8) and 2–4 weeks after chemotherapy. They also completed a self-report nausea and vomiting (NV) diary for 5–7 days after chemotherapy. To determine the effects of PCNV on HQL, the change in scores between the baseline and day 8 HQL assessments was calculated for each domain and symptom in the QLQ-C30 and compared in four subgroups of patients: those with both nausea and vomiting, those with nausea but no vomiting, those with no nausea but with vomiting, and those with neither nausea nor vomiting. The group with both nausea and vomiting showed statistically significantly worse physical, cognitive and social functioning, global quality of life, fatigue, anorexia, insomnia and dyspnea as compared to the group with neither nausea nor vomiting (0.0001<P<0.05). Patients with only nausea but no vomiting tended to have less worsening in functioning and symptoms than those having both nausea and vomiting. Increased severity of vomiting (>2 episodes) was associated with worsening of only global quality of life and anorexia as compared with 1–2 episodes of vomiting (0.0001<P<0.01). By 2–4 weeks after chemotherapy all HQL scores had either returned to their baseline levels or were better than baseline. PCNV adversely affects several quality-of-life domains, but patients with only nausea experience less disruption than do those with both nausea and vomiting. Patients with 1–2 episodes of vomiting experience almost the same degree of disruption of HQL as do patients with more than 2 episodes of vomiting. 相似文献
6.
Beth Bjerregaard M.D. Benny Andreasson M.D. Jakob Visfeldt M.D. Johannes E. Bock M.D. 《Gynecologic oncology》1993,50(3)
The material consists of a series of 73 patients with squamous cell carcinoma of the vulva. The site and the size of the primary tumor and the histological status of the lymph nodes of the groin were known. Two pathologists evaluated nuclear hyperchromatism, nuclear polymorphism, histological differentiation, number of mitoses, inflammatory response, and vascular invasion and graded these parameters from one to three. The reliability of the histopathological grades evaluated by the κ coefficient showed considerable interobserver variation. Despite this a model which included the subjective parameter nuclear hyperchromatism could predict patients without lymph node metastases. The model consisted of patients with tumors which were not situated on the clitoris, were less than 40 mm in diameter, and exhibited only slight hyperchromatism. The model fitted 19 (26%) and 14 (19%) of the patients with two different pathologists evaluating the nuclear hyperchromatism and none of these patients had lymph node metastases. The quantitative parameter—mean nuclear volume—determined by morphometry was of no diagnostic value for the prediction of patients without groin node metastases at the time of operation. 相似文献
7.
8.
Primm BJ Perez L Dennis GC Benjamin L Clark W Keough K Leak WD Payne R Smith D Sullivan LW;National Medical Association 《Journal of the National Medical Association》2004,96(9):1152-1161
ISSUE: Inadequate pain management is a serious public health problem that affects a wide cross-section of Americans. Patients are often denied sufficient medication, because physicians lack training and fear scrutiny from federal and state regulatory agencies. In addition, even the state-financed system of care, Medicaid, has been increasingly denying payment for the best treatment for pain management. These factors are complicated by physician bias about various subgroups and poor physician-patient communication. Comprehensive patient assessment plays a crucial role in determining appropriate treatment and identifying potential abuse problems. Physicians must routinely document medications analgesic effects and screen for potential ill effects and drug abuse. OBJECTIVE: To examine the prevalence of the undertreatment of pain, particularly among African Americans, and to recommend relevant proactive policy and practice changes to aid in eliminating this health problem. CONSENSUS PROCESS: In July 2002, the NMA convened the "Managing Pain: The Challenge in Underserved Populations: Appropriate Use versus Abuse and Diversion" Consensus Meeting in Washington, DC. The country's most renowned experts in the area of pain management and substance abuse reviewed substantial information regarding pain management and substance abuse including the following: --A draft summary paper on pain management and substance abuse that served as briefing material for consensus members; --Annotated bibliographies; --Articles on pain management and substance abuse; and --Key presentations on pain management and substance abuse. 相似文献
9.
Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics 下载免费PDF全文
Lee SC Antony A Lee N Leibow J Yang JQ Soviero S Gutekunst K Rosenstraus M 《Journal of clinical microbiology》2000,38(11):4171-4179
10.
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer 总被引:3,自引:0,他引:3
Finkelstein SE Heimann DM Klebanoff CA Antony PA Gattinoni L Hinrichs CS Hwang LN Palmer DC Spiess PJ Surman DR Wrzesiniski C Yu Z Rosenberg SA Restifo NP 《Journal of leukocyte biology》2004,76(2):333-337
Immunotherapy using adoptive cell transfer is a promising approach that can result in the regression of bulky, invasive cancer in some patients. However, currently available therapies remain less successful than desired. To study the mechanisms of action and possible improvements in cell-transfer therapies, we use a murine model system with analogous components to the treatment of patients. T cell receptor transgenic CD8+ T cells (pmel-1) specifically recognizing the melanocyte differentiation antigen gp100 are adoptively transferred into lympho-depleted mice bearing large, established, 14-day subcutaneous B16 melanoma (0.5-1 cm in diameter) on the day of treatment. Adoptive cell transfer in combination with interleukin interleukin-2 or interleukin-15 cytokine administration and vaccination using an altered form of the target antigen, gp100, can result in the complete and durable regression of large tumor burdens. Complete responders frequently develop autoimmunity with vitiligo at the former tumor site that often spreads to involve the whole coat. These findings have important implications for the design of immunotherapy trials in humans. 相似文献